Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 1 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 36 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
De Grave Vreugde Therapeutics from Antwerpen, company number BE1019638561, closed financial year 2025 with a result of € -10,632 after tax. For that financial year De Grave Vreugde Therapeutics recorded a gross margin of € -10,092 and equity of € -7,632. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 4, 2026.
€ -7,632
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -10,632
Profit after tax over the fiscal year.
€ 466
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -10,632.
People and assets in 2025
€ 7,006
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 407
Loans from banks and other lenders, long and short.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to De Grave Vreugde Therapeutics?
What happened at De Grave Vreugde Therapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 10,632. filed late Source: NBB ↗
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
A new publication or filing at De Grave Vreugde Therapeutics? We notify you, reason included.
Follow De Grave Vreugde TherapeuticsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Venneborglaan 78
2100 Antwerpen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1019.638.561
- VAT number
- BE 1019.638.561
- Registered office
- Venneborglaan 78, 2100 Antwerpen
- Names & denominations
- De Grave Vreugde Therapeutics
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 February 2025
- Peppol
- Active · Active since 19 Dec 2025